Order Article Reprints

Susilo H, Pikir BS, Thaha M, Alsagaff MY, Suryantoro SD, Wungu CDK, Wafa IA, Pakpahan C, Oceandy D. The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level. Genes. 2022; 13(7):1121. https://doi.org/10.3390/genes13071121

Susilo, Hendri, Budi Susetyo Pikir, Mochammad Thaha, Mochamad Yusuf Alsagaff, Satriyo Dwi Suryantoro, Citrawati Dyah Kencono Wungu, Ifan Ali Wafa, Cennikon Pakpahan, and Delvac Oceandy. 2022. "The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level" Genes 13, no. 7: 1121. https://doi.org/10.3390/genes13071121

Susilo, H., Pikir, B. S., Thaha, M., Alsagaff, M. Y., Suryantoro, S. D., Wungu, C. D. K., Wafa, I. A., Pakpahan, C., & Oceandy, D. (2022). The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level. Genes, 13(7), 1121. https://doi.org/10.3390/genes13071121